Name: Creatinolfosfate
Text:
Creatinolfosfate is a phosphoethanolamine.
COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory Degenerative Joint Disease. COP has been investigated for the treatment of Diabetic Retinopathy.
CREATINOLFOSFATE is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication.
Properties:safety: Irritant
smiles: CN(CCOP(=O)(O)O)C(=N)N
formula: C4H12N3O4P
chem_properties: Molecular Weight: 197.13 g/mol
XLogP3: -2.5
Hydrogen Bond Donor Count: 4
Hydrogen Bond Acceptor Count: 5
Rotatable Bond Count: 5
Exact Mass: 197.05654287 Da
Monoisotopic Mass: 197.05654287 Da
Topological Polar Surface Area: 120
Heavy Atom Count: 12
Formal Charge: 0
Complexity: 202
Isotope Atom Count: 0
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count: 0
Defined Bond Stereocenter Count: 0
Undefined Bond Stereocenter Count: 0
Covalently-Bonded Unit Count: 1
Compound Is Canonicalized: Yes 

